SQI Financial Statements From 2010 to 2024

SQIDFDelisted Stock  USD 0.01  0.00  0.00%   
SQI Diagnostics financial statements provide useful quarterly and yearly information to potential SQI Diagnostics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on SQI Diagnostics financial statements helps investors assess SQI Diagnostics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting SQI Diagnostics' valuation are summarized below:
SQI Diagnostics does not now have any fundamental trend indicators for analysis.
Check SQI Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SQI Diagnostics' main balance sheet or income statement drivers, such as , as well as many indicators such as . SQI financial statements analysis is a perfect complement when working with SQI Diagnostics Valuation or Volatility modules.
  
This module can also supplement various SQI Diagnostics Technical models . Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

SQI Diagnostics Company Return On Equity Analysis

SQI Diagnostics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current SQI Diagnostics Return On Equity

    
  -12.54  
Most of SQI Diagnostics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SQI Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, SQI Diagnostics has a Return On Equity of -12.5407. This is 47.68% lower than that of the Health Care Equipment & Supplies sector and 87.74% higher than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

SQI Diagnostics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining SQI Diagnostics's current stock value. Our valuation model uses many indicators to compare SQI Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SQI Diagnostics competition to find correlations between indicators driving SQI Diagnostics's intrinsic value. More Info.
SQI Diagnostics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SQI Diagnostics' earnings, one of the primary drivers of an investment's value.

About SQI Diagnostics Financial Statements

SQI Diagnostics stakeholders use historical fundamental indicators, such as SQI Diagnostics' revenue or net income, to determine how well the company is positioned to perform in the future. Although SQI Diagnostics investors may analyze each financial statement separately, they are all interrelated. For example, changes in SQI Diagnostics' assets and liabilities are reflected in the revenues and expenses on SQI Diagnostics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in SQI Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada. Sqi Diagnostics is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Consideration for investing in SQI Pink Sheet

If you are still planning to invest in SQI Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SQI Diagnostics' history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins